Study of PD-L1 Expression with Association of Pathological Factors and Molecular Subtypes in Breast Carcinoma

Background  Programmed death ligand 1 (PD-L1), expressed on cancer cells, shows varied results in the prognosis of breast cancer. This study was conducted to study the expression of PD-L1 in breast carcinoma and to correlate it with pathological, molecular classification and prognostic factors. Mate...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Abhishek, Chandra, Smita, Chauhan, Neena, Arora, Anshika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750753/
https://www.ncbi.nlm.nih.gov/pubmed/36531539
http://dx.doi.org/10.1055/s-0042-1757232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750753/
https://www.ncbi.nlm.nih.gov/pubmed/36531539
http://dx.doi.org/10.1055/s-0042-1757232

Ejemplares similares